![Francois Maisonrouge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francois Maisonrouge
Presidente presso Pasteur Foundation
Posizioni attive di Francois Maisonrouge
Società | Posizione | Inizio | Fine |
---|---|---|---|
Équilibre BioPharmaceuticals Corp.
![]() Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Direttore/Membro del Consiglio | - | - |
Pasteur Foundation
![]() Pasteur Foundation Miscellaneous Commercial ServicesCommercial Services Pasteur Foundation operates as a research center. The private company is based in New York, NY. | Presidente | - | - |
Storia della carriera di Francois Maisonrouge
Precedenti posizioni note di Francois Maisonrouge
Società | Posizione | Inizio | Fine |
---|---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
![]() Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Presidente | - | - |
EVERCORE INC. | Corporate Officer/Principal | 30/05/2007 | - |
Formazione di Francois Maisonrouge
Harvard University | Masters Business Admin |
Ecole Centrale Lyon | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Francia | 2 |
Posizioni
Chairman | 2 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Settori
Finance | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
EVERCORE INC. | Finance |
Aziende private | 3 |
---|---|
Credit Suisse Securities (USA) LLC (Broker)
![]() Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
Pasteur Foundation
![]() Pasteur Foundation Miscellaneous Commercial ServicesCommercial Services Pasteur Foundation operates as a research center. The private company is based in New York, NY. | Commercial Services |
Équilibre BioPharmaceuticals Corp.
![]() Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Health Technology |
- Borsa valori
- Insiders
- Francois Maisonrouge
- Esperienza